【24h】

Asthma costs

机译:哮喘费用

获取原文

摘要

Until around twenty years ago, asthma was a disease which was not really at the forefront of people's or health authorities' minds in several European countries. Even in developed countries only asthmatics or parents of asthmatic children gave any weight to asthma's more important pathologies in the face of the widespread minimisation. It took a series of epidemiological studies conducted in several countries for more apt asthma research and awareness to emerge. Comparative epidemiology studies spanning two-or-more decade periods show that asthma is progressively increasingly, becoming a real public health problem. It was in the 1990s that asthma became understood as a chronic inflammatory disease, one causing early infirmity. As asthma is a disease of this type, a lifelong condition once it onsets, the costs inherent in treating it are important in the planning of prevention and reduction strategies, in strategies for improving diagnosis and treatment and for aiding patient recovery.
机译:直到二十多年前,哮喘是一种疾病,这并不是真正处于几个欧洲国家人民或卫生当局思想的最前沿。即使在发达国家中,哮喘的哮喘或哮喘的父母也会在面对广泛的最小化方面给予哮喘的更重要的病态。在若干国家进行了一系列流行病学研究,以获得更多APT哮喘的研究和意识。比较流行病学研究跨越两年或更多十年时期,表明哮喘越来越多地成为一个真正的公共卫生问题。它在20世纪90年代,哮喘被理解为慢性炎症疾病,一个导致早期的虚弱。由于哮喘是这种类型的疾病,终身状况一旦它持续,治疗所固有的成本在预防和减少策略方面是改善诊断和治疗的策略以及辅助患者恢复的策略中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号